2seventy bio, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.86 | -$0.63 | -$0.75 |
| Q2 2024 | 3 | -$0.76 | -$0.56 | -$0.67 |
| Q3 2024 | 1 | -$0.22 | -$0.16 | -$0.19 |
| Q4 2024 | 1 | -$0.38 | $0.21 | -$0.11 |
| Q1 2025 | 2 | -$0.12 | -$0.09 | -$0.10 |
| Q2 2025 | 1 | -$0.08 | -$0.06 | -$0.07 |
| Q3 2025 | 1 | -$0.04 | -$0.03 | -$0.04 |
| Q4 2025 | 1 | $0.07 | $0.09 | $0.08 |
2seventy bio, Inc. Earnings Date And Information
2seventy bio, Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.18 earnings per share for the quarter, missing analysts' consensus estimates of $-0.14 by $0.04. The company had revenue of 13.53 M for the quarter and had revenue of 100.39 M for the year. 2seventy bio, Inc. has generated $-4 earnings per share over the last year ($-4.42 diluted earnings per share) and currently has a price-to-earnings ratio of -2. 2seventy bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based on prior year's report dates.
2seventy bio, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.14 | -$0.19 | -0.05 | $16.18 M | $13.53 M |
| 08/08/2024 | Q2 2024 | $0.48 | $11.08 M | $8.97 M | ||
| 05/09/2024 | Q1 2024 | -$1.01 | $12.44 M | |||
| 03/07/2024 | Q4 2023 | -$1.11 | $10.68 M | |||
| 12/01/2023 | Q3 2023 | -$1.40 | $31.18 M | $12.03 M | ||
| 12/01/2023 | Q2 2023 | -$0.83 | $36.84 M | $36.05 M | ||
| 12/01/2023 | Q1 2023 | -$0.98 | $41.62 M | |||
| 12/01/2023 | Q4 2022 | -$0.60 | $56.18 M | |||
| 11/07/2022 | Q3 2022 | -$1.74 | -$1.75 | -0.01 | $12.37 M | $13.41 M |
| 08/10/2022 | Q2 2022 | -$2.08 | -$2.02 | 0.06 | $16.52 M | $13.48 M |
| 05/12/2022 | Q1 2022 | -$1.73 | -$3.03 | -1.3 | $8.43 M | |
| 03/22/2022 | Q4 2021 | -$2.45 | -$2.59 | -0.14 | $16.03 M | |
| 12/01/2021 | Q3 2021 | -$2.71 | -$2.58 | 0.13 | $8.52 M | $19.26 M |
| 06/30/2021 | Q2 2021 | -$3.61 | $7.33 M | |||
| 03/31/2021 | Q1 2021 | -$3.74 | $11.90 M | |||
| 12/30/2020 | Q4 2020 | -$3.30 | $9.91 M | |||
| 09/29/2020 | Q3 2020 | -$3.10 | $18.43 M | |||
| 06/29/2020 | Q2 2020 | $0.62 | $109.89 M | |||
| 03/30/2020 | Q1 2020 | $0.62 | $109.89 M |
2seventy bio, Inc. Earnings: Frequently Asked Questions
-
When is 2seventy bio, Inc.'s earnings date?
2seventy bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based off last year's report dates.
-
How can I listen to 2seventy bio, Inc.'s earnings conference call?
The conference call for 2seventy bio, Inc.'s latest earnings report can be listened to online.
-
How can I read 2seventy bio, Inc.'s conference call transcript?
The conference call transcript for 2seventy bio, Inc.'s latest earnings report can be read online.
-
How much revenue does 2seventy bio, Inc. generate each year?
2seventy bio, Inc. (:TSVT) has a recorded annual revenue of $100.39 M.
-
How much profit does 2seventy bio, Inc. generate each year?
2seventy bio, Inc. (:TSVT) has a recorded net income of $100.39 M. 2seventy bio, Inc. has generated $-4.42 earnings per share over the last four quarters.
-
What is 2seventy bio, Inc.'s price-to-earnings ratio?
2seventy bio, Inc. (:TSVT) has a price-to-earnings ratio of -2 and price/earnings-to-growth ratio is -0.05.
